{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:19:23Z","timestamp":1774739963680,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,16]]},"abstract":"<jats:p>Enterovirus 71 (EV71) vaccine for hand-foot-and-mouth disease (HFMD) prevention has been available for several years. However, as a new vaccine, the impact of EV71 vaccination on the epidemiology and etiology of HFMD is currently unclear. The purpose of this study was to compare and analyze the changes of epidemiological characteristics and etiology of HFMD patients after the introduction of EV71 vaccine. The data of hospitalized children with HFMD from 2014 to 2020 were collected from the case record department of a tertiary children hospital of Anhui Province. The changes of epidemiological characteristics, time distribution, disease severity and enterovirus serotypes in hospitalized children were analyzed. A total of 7373 cases of HFMD were reported during 2014 to 2020, including 634 (8.6%) severe cases. The number of cases reached the peak in 2016 (n\u2005=\u20051783) and decreased gradually after EV71 vaccination. The results of etiological test showed the positive rate was 80.5%, in which EV71 accounted for 1599 (21.7%) and CV-A16 accounted for 1028 (13.9%) respectively. The number of patients showed a bimodal distribution throughout the year, which were April to June and October to November. The age distribution changed significantly following the introduction of EV71 vaccine. The proportion of 1-year-old group of post-vaccination was significantly higher than that of pre-vaccination (61.9% vs 50.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). The proportion of HFMD caused by EV71 and severe cases decreased significantly after the vaccination (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001 for both). While the comparison of epidemiological characteristics and enterovirus serotypes between unvaccinated and vaccinated cases during 2017 to 2020 showed no significant difference. The dominant enterovirus serotypes of hospitalized HFMD changed significantly after the introduction of EV71 vaccine. The proportion of severe cases decreased significantly after the vaccination, but EV71 was still a major pathogen in patients with severe HFMD. More age-appropriate children are recommended to get vaccinated to establish stronger herd immunity in the population.<\/jats:p>","DOI":"10.1097\/md.0000000000030356","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T13:10:27Z","timestamp":1663593027000},"page":"e30356","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Effect of enterovirus 71 vaccination on the epidemiological characteristics and etiology in hospitalized children with hand-foot-and-mouth disease: A retrospective study from a tertiary children\u2019s hospital"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-0908","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Anhui Provincial Children\u2019s Hospital, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Anhui Provincial Children\u2019s Hospital, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Anhui Provincial Children\u2019s Hospital, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Anhui Provincial Children\u2019s Hospital, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Anhui Provincial Children\u2019s Hospital, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(14)70973-9","article-title":"Hand, foot, and mouth disease in mainland China.","volume":"14","author":"Lu","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajic.2011.01.015","article-title":"Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease.","volume":"39","author":"Kadurugamuwa","year":"2011","journal-title":"Am J Infect Control"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2334-13-489","article-title":"Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis.","volume":"13","author":"Xu","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jech-2014-203836","article-title":"Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges.","volume":"68","author":"Sabanathan","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease.","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China.","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e87603","DOI":"10.1371\/journal.pone.0087603","article-title":"Study on risk factors for severe hand, foot and mouth disease in China.","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s12889-020-08961-6","article-title":"Epidemiological and clinical characteristics of severe hand-foot-and-mouth disease (HFMD) among children: a 6-year population-based study.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Public Health"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiw502","article-title":"2-year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study.","volume":"215","author":"Wei","year":"2017","journal-title":"J Infect Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children.","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study.","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R13-20250504","first-page":"161","article-title":"Diagnosis and treatment guideline on hand, foot and mouth disease (2018 Version).","volume":"11","year":"2018","journal-title":"Chin J Clin Infect Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/j.vaccine.2018.05.054","article-title":"Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.","volume":"36","author":"Li","year":"2018","journal-title":"Vaccine"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7883\/yoken.JJID.2009.471","article-title":"Surveillance of enterovirus infections in Yokohama city from 2004 to 2008.","volume":"62","author":"Momoki","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e0135503","DOI":"10.1371\/journal.pone.0135503","article-title":"Clinical features for mild hand, foot and mouth disease in China.","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"638871","DOI":"10.3389\/fped.2021.638871","article-title":"The protective role of maternal immunization in early life.","volume":"9","author":"Cinicola","year":"2021","journal-title":"Front Pediatr"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3201\/1504.081550","article-title":"Enterovirus 71 maternal antibodies in infants, Taiwan.","volume":"15","author":"Luo","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","article-title":"Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/INF.0000000000000900","article-title":"Seroprevalence of enterovirus 71 antibody among children in China: a systematic review and meta-analysis.","volume":"34","author":"Yang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e21116","DOI":"10.1371\/journal.pone.0021116","article-title":"The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam.","volume":"6","author":"Tran","year":"2011","journal-title":"PLoS One"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1743-422X-7-300","article-title":"Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008.","volume":"7","author":"Zhu","year":"2010","journal-title":"Virol J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","article-title":"Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.","volume":"199","author":"Rabenau","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e65585","DOI":"10.1371\/journal.pone.0065585","article-title":"Short-term effect of El Ni\u00f1o-Southern Oscillation on pediatric hand, foot and mouth disease in Shenzhen, China.","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1017\/S0950268813002938","article-title":"Hand-foot-and-mouth disease and weather factors in Guangzhou, southern China.","volume":"142","author":"Li","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1461-0248.2005.00879.x","article-title":"Seasonality and the dynamics of infectious diseases.","volume":"9","author":"Altizer","year":"2006","journal-title":"Ecol Lett"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.epidem.2013.01.001","article-title":"Indirect transmission and the effect of seasonal pathogen inactivation on infectious disease periodicity.","volume":"5","author":"Robinson","year":"2013","journal-title":"Epidemics"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/EDE.0b013e318231d67a","article-title":"Hand, foot, and mouth disease in China: patterns of spread and transmissibility.","volume":"22","author":"Wang","year":"2011","journal-title":"Epidemiology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1016\/j.cub.2021.01.006","article-title":"Herd immunity.","volume":"31","author":"Ashby","year":"2021","journal-title":"Curr Biol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/INF.0000000000002745","article-title":"Epidemiology of hand, foot, and mouth disease before and after the introduction of enterovirus 71 vaccines in Chengdu, China, 2009-2018.","volume":"39","author":"Han","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R31-20250504","first-page":"697","article-title":"Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007-May 2008.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.2008-3528","article-title":"Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine.","volume":"124","author":"Tate","year":"2009","journal-title":"Pediatrics"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/INF.0b013e3181c18434","article-title":"Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children.","volume":"29","author":"Paulke-Korinek","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/aje\/155.10.891","article-title":"Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program.","volume":"155","author":"Pr\u00e9ziosi","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R36-20250504","first-page":"20","article-title":"COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.","volume":"29","author":"Ochani","year":"2021","journal-title":"Infez Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"728768","DOI":"10.3389\/fpubh.2021.728768","article-title":"Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19.","volume":"9","author":"Chen","year":"2021","journal-title":"Front Public Health"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1038\/s41467-021-27292-7","article-title":"Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.","volume":"12","author":"Geng","year":"2021","journal-title":"Nat Commun"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.puhip.2022.100278","article-title":"The indirect impact of control measures in COVID-19 pandemic on the incidence of other infectious diseases in China.","volume":"4","author":"Song","year":"2022","journal-title":"Public Health Pract (Oxf)"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/jmv.27715","article-title":"The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-a spatiotemporal perspective in Xi\u2019an, northwestern China.","volume":"94","author":"Shen","year":"2022","journal-title":"J Med Virol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:44:14Z","timestamp":1746333854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030356","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}